Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, 80138 Naples, Italy.
Unit of Endocrinology and Metabolic Diseases, University Hospital Luigi Vanvitelli, 80138 Naples, Italy.
J Clin Endocrinol Metab. 2022 Aug 18;107(9):e3910-e3918. doi: 10.1210/clinem/dgac316.
Endothelial progenitor cells (EPCs), which are involved in the mechanisms of vascular repair and sexual function, are decreased in diabetic women compared with general population.
This work aimed to investigate the circulating levels of EPCs and the change in sexual function during the menstrual cycle in women with type 1 diabetes (T1DM) compared with healthy women.
This case-control observational study was conducted at the Unit of Endocrinology and Metabolic Diseases at University Hospital "Luigi Vanvitelli'' of Naples. Participants included 36 women with T1DM and 64 age-matched healthy controls. EPCs were quantified by flow cytometry and sexual function was assessed using the Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale. All assessments were made at the follicular, ovulatory, and luteal phases of the same menstrual cycle. Main outcome measures included differences in EPCs levels and sexual function between patients and controls.
Compared with controls, women with T1DM showed significantly lower levels of both CD34 + (P < .001) and CD34 + CD133 + cells (P < .001) in the ovulatory phase, and CD34 + KDR + cells both in the ovulatory phase and in the luteal phase (P < .001 for both). Diabetic women showed significantly lower total FSFI scores and higher FSDS score than control women in all phases of the menstrual cycle. FSFI total score was predicted by both CD34 + CD133 + and CD34 + KDR + cells in the follicular phase, CD34 + and CD34 + KDR + CD133 + cells in the ovulatory phase, and CD34 + KDR + and CD34 + KDR + CD133 + cells in the luteal phase.
Women with T1DM show lower levels of EPCs during the menstrual cycle compared with controls. EPCs count predicts sexual function in this selected population.
与普通人群相比,1 型糖尿病(T1DM)女性的内皮祖细胞(EPCs)减少,而 EPCs 参与血管修复和性功能的机制。
本研究旨在比较 T1DM 女性与健康女性在月经周期中循环 EPCs 水平和性功能的变化。
这项病例对照观察性研究在那不勒斯 Luigi Vanvitelli 大学医院内分泌和代谢疾病科进行。参与者包括 36 名 T1DM 女性和 64 名年龄匹配的健康对照者。通过流式细胞术定量 EPCs,使用女性性功能指数(FSFI)和女性性功能障碍量表(FSDS)评估性功能。所有评估均在同一月经周期的卵泡期、排卵期和黄体期进行。主要观察指标包括患者和对照组之间 EPCs 水平和性功能的差异。
与对照组相比,T1DM 女性在排卵期的 CD34+(P<0.001)和 CD34+CD133+细胞(P<0.001)水平明显较低,排卵期和黄体期的 CD34+KDR+细胞(两者均为 P<0.001)水平明显较低。在所有月经周期阶段,糖尿病女性的总 FSFI 评分均明显低于对照组女性,FSDS 评分均明显高于对照组女性。在卵泡期,FSFI 总评分与 CD34+CD133+和 CD34+KDR+细胞相关;在排卵期,与 CD34+和 CD34+KDR+CD133+细胞相关;在黄体期,与 CD34+KDR+和 CD34+KDR+CD133+细胞相关,均能预测 FSFI 总评分。
与对照组相比,T1DM 女性在月经周期中 EPCs 水平较低。EPCs 计数可预测该特定人群的性功能。